PUT/MERCK & CO./55/0.1/21.06.24 Stock

Warrant

DE000GK72JB9

Market Closed - Bid/Ask 02:26:10 2024-06-13 pm EDT After market 03:55:25 pm
0.001 EUR 0.00% Intraday chart for PUT/MERCK & CO./55/0.1/21.06.24 0.051 +5,000.00%
6 months-91.67%
Current year-85.71%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-13 0.001 0.00%
24-06-12 0.001 0.00%
24-06-11 0.001 0.00%
24-06-10 0.001 0.00%
24-06-07 0.001 0.00%

Real-time BOERSE MUENCHEN

Last update June 13, 2024 at 02:26 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying MERCK & CO., INC.
Issuer Goldman Sachs
WKN GK72JB
ISINDE000GK72JB9
Date issued 2022-07-05
Strike 55 $
Maturity 2024-06-21 (8 Days)
Parity 10 : 1
Emission price 0.16
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.276
Lowest since issue 0.001
Spread 0.099
Spread %99.00%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.2 USD
Average target price
142.7 USD
Spread / Average Target
+9.59%
Consensus